These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 37072847)

  • 1. Pathogenic sphingosine 1-phosphate pathway in psoriasis: a critical review of its pathogenic significance and potential as a therapeutic target.
    Zhao Y; Zhang Y; Li J; Zhang N; Jin Q; Qi Y; Song P
    Lipids Health Dis; 2023 Apr; 22(1):52. PubMed ID: 37072847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingosine-1-Phosphate Signaling in Cardiovascular Diseases.
    Wang N; Li JY; Zeng B; Chen GL
    Biomolecules; 2023 May; 13(5):. PubMed ID: 37238688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis.
    Pérez-Jeldres T; Alvarez-Lobos M; Rivera-Nieves J
    Drugs; 2021 Jun; 81(9):985-1002. PubMed ID: 33983615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The S1P-S1PR Axis in Neurological Disorders-Insights into Current and Future Therapeutic Perspectives.
    Lucaciu A; Brunkhorst R; Pfeilschifter JM; Pfeilschifter W; Subburayalu J
    Cells; 2020 Jun; 9(6):. PubMed ID: 32580348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARγ agonists upregulate sphingosine 1-phosphate (S1P) receptor 1 expression, which in turn reduces S1P-induced [Ca(2+)]i increases in renal mesangial cells.
    Koch A; Völzke A; Puff B; Blankenbach K; Meyer Zu Heringdorf D; Huwiler A; Pfeilschifter J
    Biochim Biophys Acta; 2013 Nov; 1831(11):1634-43. PubMed ID: 23906789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine-1-Phosphate and Its Signal Modulators Alleviate Psoriasis-Like Dermatitis: Preclinical and Clinical Evidence and Possible Mechanisms.
    Liu L; Wang J; Li HJ; Zhang S; Jin MZ; Chen ST; Sun XY; Zhou YQ; Lu Y; Yang D; Luo Y; Ru Y; Li B; Li X
    Front Immunol; 2021; 12():759276. PubMed ID: 34992595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival benefit of sphingosin-1-phosphate and receptors expressions in breast cancer patients.
    Lei FJ; Cheng BH; Liao PY; Wang HC; Chang WC; Lai HC; Yang JC; Wu YC; Chu LC; Ma WL
    Cancer Med; 2018 Aug; 7(8):3743-3754. PubMed ID: 29923327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosine-1-phosphate signaling in physiology and diseases.
    Takuwa Y; Okamoto Y; Yoshioka K; Takuwa N
    Biofactors; 2012; 38(5):329-37. PubMed ID: 22674845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosine 1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P2 and S1P3 receptors and Smad-independent signaling.
    Sobel K; Menyhart K; Killer N; Renault B; Bauer Y; Studer R; Steiner B; Bolli MH; Nayler O; Gatfield J
    J Biol Chem; 2013 May; 288(21):14839-51. PubMed ID: 23589284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting sphingosine-1-phosphate receptors in cancer.
    Watters RJ; Wang HG; Sung SS; Loughran TP; Liu X
    Anticancer Agents Med Chem; 2011 Nov; 11(9):810-7. PubMed ID: 21707490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of sphingosine-1-phosphate in cardiovascular physiology and pathology.
    Jozefczuk E; Guzik TJ; Siedlinski M
    Pharmacol Res; 2020 Jun; 156():104793. PubMed ID: 32278039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The drug development based on sphingosine-1-phosphate signaling pathway].
    Bai J; Hu JP
    Yao Xue Xue Bao; 2016 Dec; 51(12):1822-8. PubMed ID: 29908533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine-1-Phosphate Induces Dose-Dependent Chemotaxis or Fugetaxis of T-ALL Blasts through S1P1 Activation.
    Messias CV; Santana-Van-Vliet E; Lemos JP; Moreira OC; Cotta-de-Almeida V; Savino W; Mendes-da-Cruz DA
    PLoS One; 2016; 11(1):e0148137. PubMed ID: 26824863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on the biology of sphingosine 1-phosphate receptors.
    Blaho VA; Hla T
    J Lipid Res; 2014 Aug; 55(8):1596-608. PubMed ID: 24459205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of sphingosine 1-phosphate receptor signalling in cancer.
    Patmanathan SN; Wang W; Yap LF; Herr DR; Paterson IC
    Cell Signal; 2017 Jun; 34():66-75. PubMed ID: 28302566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine-1-phosphate receptors: biology and therapeutic potential in kidney disease.
    Jo SK; Bajwa A; Awad AS; Lynch KR; Okusa MD
    Kidney Int; 2008 Jun; 73(11):1220-30. PubMed ID: 18322542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine-1-phosphate/sphingosine-1-phosphate receptor 1 and T cell migration.
    Zhuang XP; Zhu Q
    Yao Xue Xue Bao; 2016 Jun; 51(6):873-8. PubMed ID: 29878740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation.
    Tsai HC; Han MH
    Drugs; 2016 Jul; 76(11):1067-79. PubMed ID: 27318702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular sphingosine-1-phosphate S1P1 and S1P3 receptors.
    Waeber C; Blondeau N; Salomone S
    Drug News Perspect; 2004; 17(6):365-82. PubMed ID: 15334188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating levels of sphingosine-1-phosphate are elevated in severe, but not mild psoriasis and are unresponsive to anti-TNF-α treatment.
    Checa A; Xu N; Sar DG; Haeggström JZ; Ståhle M; Wheelock CE
    Sci Rep; 2015 Jul; 5():12017. PubMed ID: 26174087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.